2005-06-01
Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
Publication
Publication
Critical Care , Volume 9 - Issue 3 p. 257- 258
In a retrospective study, Dr Muller and colleagues have assessed the efficacy of mupirocin nasal ointment alongside hygienic measures in methicillin-resistant Staphylococcus aureus (MRSA)-positive patients admitted to the intensive care unit (ICU). Their findings, which suggest that intranasal mupirocin can prevent ICU-related MRSA infections, need confirmation in a well-designed clinical trial. In general: early identification, isolation and treatment of all MRSA carriers, including health care workers, and disinfection of contaminated environments, are the main 'ingredients' of an effective MRSA 'search and destroy' program.
| Additional Metadata | |
|---|---|
| , , , , , , , | |
| doi.org/10.1186/cc3720, hdl.handle.net/1765/17743 | |
| Staphylococcus aureus: Resources | |
| Critical Care | |
| Organisation | Erasmus MC: University Medical Center Rotterdam |
|
Wertheim, H., & Vos, M. (2005). Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?. Critical Care, 9(3), 257–258. doi:10.1186/cc3720 |
|
